A Randomized Controlled Study on the Effect of MRJPs on Improving Ovarian Function and Endometrial Receptivity

ConditionsDiminished Ovarian Reserve (DOR)Thin Endometrium

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexFemale

Age20-45

SponsorThe Fourth Affiliated Hospital of Zhejiang University School of Medicine

About this trial

This study will assess the effects of the rose tablet candies produced by MRJPs on the subjects, evaluate the role of MRJPs in the ovarian function and endometrial receptivity of women, reveal the potential application value of MRJPs in reproductive health, and determine its safety and effectiveness.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Fertile women, aged 20 to 45 years old, with regular and normal menstrual cycles.

Disqualifiers

① Allergic to royal jelly or its components; ② Suffering from severe chronic diseases or endocrine system disorders; ③ Pregnant or breastfeeding; ④ Undergoing hormone replacement therapy (HRT) within the last month

Trial design

Design model

Parallel

Treatments tested in this trial

Oral MRJPs Candy
Dietary supplement
500 mg per tablet, containing 70% MRJPs freeze-dried powder + 20% sodium cellulose + 10% microcrystalline cellulose, with an appropriate amount of arabinose, taken twice a day, 1 tablet each time, for a total of 1 menstrual cycle in the control group.
Oral placebo candy
Dietary supplement
500 mg per tablet, containing 70% whey protein powder + 20% sodium cellulose + 10% microcrystalline cellulose, with appropriate amount of arabinose, taken twice a day, 1 tablet each time, for a total of 1 menstrual cycle in the control group.

Treatment groups

66 Participants

are divided into 2 treatment groups

Group A: Experimental groupExperimental treatment 1 intervention

Group B: Control groupPlacebo comparator 1 intervention

Trial outcomes